Supplier News: Piramal, Codis, Fujifilm Bio & More
The latest from CDMOs, CMOs, and suppliers featuring Piramal Pharma Solutions, Codis, Fujifilm Biotechnologies, Nuecell Bio and Altasciences.
Chemicals/Chemical API Manufacturing
* Piramal Pharma Adds Spray-Drying Suite in Peptide API Facility
Biologics Manufacturing
* NueCell-Bio Launches as Cell Therapy CDMO
Formulation Development/Drug Product Manufacturing
* Codis Completes Acquisition of Catalent Spray-Drying Facility
* Altascience Expands Drug Product R&D Lab
Appointments
* Fujifilm Biotechnologies Names New CEO in Planned Succession
Chemicals/Chemical API Manufacturing
Piramal Pharma Adds Spray-Drying Suite in Peptide API Facility
Piramal Pharma Solutions, a CDMO of active pharmaceutical ingredients and drug products, has added a spray-drying suite at its dedicated peptide development and manufacturing facility in Turbhe, India, to enable the formulation of challenging molecules, including peptides, high-potency active pharmaceutical ingredients, and other biomolecules.
The new spray-drying suite operates as a closed-loop system, equipped with its own inert gas supply and advanced safety measures, including specialized HVAC, airlocked entries and exits, operator isolation, and a dedicated cleaning area to enable the safe handling of potent compounds and organic solvents requiring up to Band 5 containment. To further strengthen these capabilities, the processing area maintains ISO Class 8 (Class 100,000) standards.
Source: Piramal Pharma Solutions
Biologics Manufacturing
NueCell-Bio Launches as Cell Therapy CDMO
NueCell Bio has launced as a new CDMO of cell therapies. NueCell Bio is headquartered in the Sorrento Valley area of San Diego in a 26,300-square-foot-facility that specializes in translational services for cell therapies.
Source: NueCell Bio
Formulation Development/Drug Product Manufacturing
Codis Completes Acquisition of Catalent Spray-Drying Facility
Codis, a contract provider specializing in commercial-scale spray drying, amorphous solid dispersions, and particle-engineering technologies, has completed its acquisition of the Nottingham, UK, facility of Catalent Pharma Solutions. The facility provides oral solid dose development and small-scale manufacturing capabilities.
The facility will complement Codis’ large-scale commercial spray-drying facility in Haverhill, UK, which is now undergoing expansion with a new GEA Pharma-SD type PSD-4 commercial spray dryer scheduled to be validated in 2027.
Source: Codis
Altascience Expands Drug Product R&D Lab
Altasciences, a Laval, Quebec, Canada-based CDMO, has expanded the R&D laboratory at its drug-product formulation and manufacturing services facility in Harleysville, Pennsylvania, adding approximately 768 square feet of new laboratory space.
The enhanced laboratory supports phase-appropriate, target product profile-driven formulation screening. Capabilities include formulation development for small molecules, peptides, and complex modalities, as well as non-GLP and GLP toxicology samples for nonclinical studies.
Source: Altasciences
Appointments
Fujifilm Biotechnologies Names New CEO in Planned Succession
Fujifilm Biotechnologies has appointed Maja Pedersen, currently Chief Operating Officer of the company, to President, in addition to her role as Chief Operating Officer, effective immediately (as reported on August 4, 2026). The appointment is part of a planned leadership succession with Lars Petersen, formerly President and CEO of the company, who is transitioning his role to a Strategic Advisor, through September 30, 2026.
Maja Pedersen was appointed to Chief Operating Officer in 2025, and in that role, she is responsible for site operations, supply chain, quality, process development, and global manufacturing science and technology. Before that, she was the company’s Chief Quality Officer, overseeing the organization’s global quality network across multiple manufacturing sites and responsible for institutionalizing global quality standards and creating a streamlined global regulatory process. Prior to that, she was Global Head of External Manufacturing at Biogen, where she oversaw the company’s CDMO network. She has over 20 years of leadership experience in life sciences and bio/pharma, holding senior leadership positions in quality assurance and control, regulatory affairs, and external manufacturing.
Source: Fujifilm Biotechnologies
